Workshops

  • Workshop A: Strategies to enhance solubility of compounds
  • Workshop D: Amorphous materials for optimised drug performance.

Interactive Workshop Day: Wednesday, 24th February 2010

09:00 - 12:00 Workshop A: Strategies to enhance solubility of compounds

The impact of solubility on drug development has led to increasing interest from the pharmaceutical industry over the past years. Still there are dozens of challenges to be delt with. That is why this workshop focusses on:

  • Is poor solubility an issue to the formulator?
  • Assessing poor solubility – selection criteria
  • Formulation approaches for poorly soluble substances
  • Formulation concepts in different phases of development
  • Formulation technologies for poorly soluble compounds and service providers

Dr. Jörg Breitenbach
Senior director drug product development, Head of SOLIQS
Abbott GmbH & Co. KG, Germany

Back to Top

13:00 - 16:00 Workshop D: Amorphous materials for optimised drug performance

Interactively we will discuss how amorphous materials are able to enhance drug performance and which work stages will lead to optimal results.

  • Different stages of amorphous materials
  • Preparation technologies
  • Analytical characterization tools
  • Prediction of physical stability
  • Screening of amorphous materials, formulations
  • Excipients used for stabilization – global ADI limits
  • Biopharmaceutical aspects – in-vivo stabilization

Dr. Carsten Timpe
Fellow
Novartis, Switzerland

Back to Top

[ Register Now ]